Particle.news
Download on the App Store

ARK Invest Tilts Toward AI With CoreWeave Buy and First Direct OpenAI Stake

The shift shows conviction in AI infrastructure despite recent fund losses.

Overview

  • ARK Invest, which bought 83,764 CoreWeave shares across March 30 to April 1, put about $6.9 million into the Nvidia‑partnered AI cloud provider as it posted 110% fourth‑quarter revenue growth but guided first‑quarter sales below forecasts.
  • ARK took its first direct cap‑table position in OpenAI, acquiring 348,995 units across ARKF, ARKK, and ARKW through a Series C allocation.
  • The firm added exposure to autonomous logistics, advanced energy, and genomics by buying Kodiak AI, Oklo, DoorDash, Arcturus Therapeutics, and GeneDx.
  • ARK rebalanced by exiting 745,000 Strata Critical Medical shares and trimming positions in Teradyne, Pinterest, Veracyte, Discovery, and LY Corp.
  • ARKK is down about 12% this year with roughly $1.2 billion in 12‑month outflows, while Wood touts a coming AI‑driven “great acceleration” and Bank of America upgraded CoreWeave to buy with a $100 target.